Buoyed by a spate of mutual-fund-to-ETF conversions, active ETFs made their presence felt in 2024. That accounted for significant percentages of both inflows and launches.

MINNEAPOLIS, March 26, 2025 (GLOBE NEWSWIRE) -- SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), an online performance-based marketing company serving the U.S. sports betting and global iGaming industries, today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has granted the Company additional time to achieve compliance with the minimum bid price requirement as set forth in Listing Rule 5550(a)(2) (the “Bid Price Rule”), which requires issuers to maintain a minimum bid price of $1.00 per share on the Nasdaq; and Listing …

PHOENIX--(BUSINESS WIRE)--Freeport (NYSE: FCX) announced today that its Board of Directors declared cash dividends of $0.15 per share on FCX's common stock payable on May 1, 2025, to shareholders of record as of April 15, 2025. The declaration includes a base dividend of $0.075 per share and variable dividend of $0.075 per share in accordance with FCX's performance-based payout framework. The payment of dividends is at the discretion of the Board, which will consider FCX's financial results, ca.

PHOENIX, March 26, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, today announced the pricing of an underwritten public offering of 2,800,000 shares of its common stock at a price to the public of $10.00 per share. Certain existing stockholders, including certain directors and/or their affiliates, have agreed to purchase an aggregate of 1,439,200 shares of our common stock in the offering.

NEW YORK--(BUSINESS WIRE)--Amex GBT Receives Credit Rating Upgrade; Moody's Upgrades the Company to B1.

Company's 6 th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology

ROCHESTER, N.Y.--(BUSINESS WIRE)--Paychex, Inc. (the "Company," "Paychex," "we," "our," or "us") today reported results for the fiscal quarter ended February 28, 2025 (the "third quarter"). Results compared with the same period last year were as follows: For the three months ended For the nine months ended In millions, except per share amounts February 28, 2025 February 29, 2024 Change(2) February 28, 2025 February 29, 2024 Change(2) Total revenue $ 1,509.0 $ 1,439.3 5 % $ 4,144.4 $ 3,983.

Houston, TX, March 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) is pleased to invite investors to a webinar on April 3, 2025, at 4:15 p.m. ET.

DENVER--(BUSINESS WIRE)--Janus Henderson Group (NYSE: JHG) (together with its subsidiaries, “Janus Henderson” or the “Company”) announced today that its subsidiary Janus Henderson US (Holdings) Inc. (the “Issuer”) has extended its offer to the holders of the $400,000,000 aggregate principal amount of 5.450% Senior Notes due 2034 (the “Notes”), to exchange the Notes (the “Exchange Offer”) for a like principal amount of new Notes with substantially identical terms other than that such new notes h.

SYDNEY, March 26, 2025 (GLOBE NEWSWIRE) -- HyFuel Solar Refinery Pty Ltd, a subsidiary of Vast Renewables Limited (Vast) (Nasdaq: VSTE), has been awarded AUD 700,000 through the Australia-Singapore Low Emissions Technologies (ASLET) initiative for maritime and port operations. The funding will progress the development of South Australia Solar Fuels (SA Solar Fuels), a world-first sustainable fuels project collaboration between Vast and global energy company Mabanaft.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Oral presentation features new data from the 24-week pivotal Vivacity-MG3 study which show sustained disease control through treatment with nipocalimab on the clinician-assessed QMGa score in antibody positive adult patients: anti-AChR+, anti-MuSK+, anti-LRP4+ Nipocalimab data demonstrate longer-term sustained disease control as measured by MG-ADLb and QMG scores from the ongoing open-label extension (OLE) of the Vivacity-MG3 study Johnson & Johnson filed a Biologics License Application (BLA) for nipocalimab in August 2024 and was granted U.S. FDA Priority Review for the treatment of gMG Real-world studies highlight the unmet need of patients living with gMG, including those who are pregnant or …

NEW YORK , March 26, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for allergic and inflammatory diseases, today announced two major developments in the ongoing advancement of its proprietary antisense oligonucleotide (ASO) cancer fighting drug candidate, HT-KIT. The Company has filed amended claims with the U.S. Patent and Trademark Office for its lead ASO technology targeting MS4A6A and FcεRIβ—genes implicated in allergic inflammation and mast cell-related diseases.

The Walt Disney Co. NYSE: DIS is a massive media and entertainment organization in the consumer discretionary sector that operates primarily under three segments: Entertainment, Sports and Experiences. While its streaming networks in the Entertainment segment are in the black, the Sports segment has had the slowest growth.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

The U.S. federal government employs roughly 2.4 million people, across over 400 agencies, not including postal workers and active-duty military personnel.

SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced positive data from three oral presentations at the 34th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL) 2025, being held March 26 - 30, 2025 in Beijing, China.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FMC Corporation (“FMC” or the “Company”) (NYSE:FMC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-01457, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired QCI securities between March 30, 2020 and January 15, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities …